Match Group, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Match Group, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.49B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $3.48B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $3.36B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $3.19B | Feb 27, 2025 |
| FY2021 | Dec 31, 2021 | $806.07M | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | $801.84M | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | $707.76M | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | $667.61M | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | $651.41M | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | $639.77M | Feb 24, 2022 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.49B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $3.48B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $3.36B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $3.19B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.98B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $2.39B | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $1.22B | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $1.25B | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $1.19B | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $1.11B | Feb 28, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2010 | Dec 31, 2010 | $99.36M | Feb 1, 2012 |
| FY2010 | Dec 31, 2009 | ($978.82M) | Feb 1, 2012 |
| FY2010 | Dec 31, 2008 | ($156.20M) | Feb 1, 2012 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $872.53M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $823.31M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $916.90M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $515.01M | Feb 27, 2025 |
| FY2021 | Dec 31, 2021 | $231.92M | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | $220.59M | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | $209.91M | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | $189.26M | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | $212.58M | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | $200.17M | Feb 24, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $449.51M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $442.18M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $384.19M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $333.64M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $241.05M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $169.81M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $151.96M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $132.03M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $250.88M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $212.77M | Mar 1, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.08B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $932.72M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $896.79M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $525.69M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $912.50M | Feb 23, 2024 |
| FY2019 | Dec 31, 2019 | $937.94M | Feb 28, 2020 |
| FY2019 | Dec 31, 2018 | $988.13M | Feb 28, 2020 |
| FY2019 | Dec 31, 2017 | $416.70M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $344.24M | Mar 1, 2019 |
| FY2017 | Dec 31, 2015 | $405.67M | Mar 1, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $56.77M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $50.58M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $67.41M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $49.13M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $79.97M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $42.38M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $39.04M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $31.40M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $75.52M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $78.04M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.46B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $4.47B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $4.51B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $4.18B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $5.06B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $3.05B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $8.36B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $6.87B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $5.87B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $4.65B | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($253.50M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | ($63.66M) | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | ($19.55M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | ($359.88M) | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | ($203.77M) | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | ($1.41B) | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $2.93B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $2.84B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $2.43B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.87B | Mar 1, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.34B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.31B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $2.34B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $2.35B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.41B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $1.27B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $1.24B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $1.25B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $2.56B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $1.92B | Mar 1, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($5.97B) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | ($6.58B) | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | ($7.13B) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | ($7.78B) | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | ($8.14B) | Feb 24, 2023 |
| FY2021 | Jan 1, 2021 | ($8.42B) | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | ($8.42B) | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.69B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $1.26B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $595.04M | Mar 1, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.03B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $965.99M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $862.44M | Feb 26, 2026 |
| FY2025 | Dec 31, 2022 | $572.40M | Feb 26, 2026 |
| FY2024 | Dec 31, 2021 | $815.38M | Feb 27, 2025 |
| FY2023 | Dec 31, 2020 | $739.16M | Feb 23, 2024 |
| FY2022 | Dec 31, 2019 | $465.68M | Feb 24, 2023 |
| FY2021 | Dec 31, 2018 | $186.95M | Feb 24, 2022 |
| FY2020 | Dec 31, 2017 | $272.62M | Feb 25, 2021 |
| FY2019 | Dec 31, 2016 | $1.33B | Feb 28, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.55B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $3.85B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $3.84B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $3.84B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $3.83B | Feb 24, 2023 |
| FY2021 | Jan 1, 2021 | $3.84B | Feb 24, 2022 |
| FY2020 | Dec 31, 2020 | $3.53B | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $2.89B | Feb 25, 2021 |
| FY2018 | Dec 31, 2018 | $2.35B | Mar 1, 2019 |
| FY2017 | Dec 31, 2017 | $2.10B | Mar 1, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 27, 2025 |
| FY2021 | Dec 31, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | 0 | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Feb 24, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 27, 2025 |
| FY2021 | Dec 31, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | 0 | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Feb 24, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 232.53M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 251.46M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 268.89M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 279.63M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | 283.47M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | 267.33M | Feb 24, 2022 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $0 | Feb 28, 2020 |
| FY2019 | Dec 31, 2018 | $105.13M | Feb 28, 2020 |
| FY2019 | Dec 31, 2017 | $0 | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $0 | Mar 1, 2019 |
| FY2017 | Dec 31, 2015 | $113.20M | Mar 1, 2018 |
| FY2016 | Dec 31, 2014 | $97.34M | Feb 28, 2017 |
| FY2015 | Dec 31, 2013 | $79.19M | Feb 29, 2016 |
| FY2014 | Dec 31, 2012 | $68.16M | Feb 27, 2015 |
| FY2013 | Dec 31, 2011 | $10.67M | Feb 26, 2014 |